APN 1808
Alternative Names: APN-1808Latest Information Update: 26 Sep 2022
At a glance
- Originator APRINOIA Therapeutics
- Class Antidementias; Small molecules
- Mechanism of Action Tau protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alzheimer's disease